Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_598513b56c015a91156bee4e430b1b05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_204ea9f0f83d1c51a916e46a41a6a14a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-224 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-12 |
filingDate |
2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c7e56647738fbd846eb43e74ac4b013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2813e6472c583110e35c05d3af30794f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a8dbe107bc15ae8cf991b0448a1675e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9d346875ff03c154ece93d4adf76df9 |
publicationDate |
2018-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2016300993-A1 |
titleOfInvention |
Novel aminoglycoside antibiotic effective against multidrug-resistant bacteria |
abstract |
Disclosed are: a compound represented by general formula (I), or a pharmaceutically acceptable salt of the compound, or a solvate of the compound or the pharmaceutically acceptable salt; a pharmaceutical composition containing the compound, the pharmaceutically acceptable salt or the solvate; a use of the compound, the pharmaceutically acceptable salt or the solvate for the prevention or treatment of infectious diseases; and a method for preventing or treating infectious diseases using the compound, the pharmaceutically acceptable salt or the solvate. The compound represented by general formula (I) has an antibacterial activity against both gram-positive bacteria and gram-negative bacteria, and is therefore useful for the prevention or treatment of infectious diseases induced by these bacteria. |
priorityDate |
2015-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |